278 related articles for article (PubMed ID: 34405435)
1. Advances in Treatment of Progressive Multifocal Leukoencephalopathy.
Bernard-Valnet R; Koralnik IJ; Du Pasquier R
Ann Neurol; 2021 Dec; 90(6):865-873. PubMed ID: 34405435
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.
Cortese I; Reich DS; Nath A
Nat Rev Neurol; 2021 Jan; 17(1):37-51. PubMed ID: 33219338
[TBL] [Abstract][Full Text] [Related]
3. Bridging the Gap: Immunotherapy in Progressive Multifocal Leukoencephalopathy: A New Hope?
Born T; Vassallo P; Golshayan D; Di Liberto G; Brouland JP; Egervari K; Merkler D; Du Pasquier RA; Bernard-Valnet R
Neurology; 2023 Sep; 101(13):e1382-e1386. PubMed ID: 37407265
[TBL] [Abstract][Full Text] [Related]
4. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
5. Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy.
Berzero G; Basso S; Stoppini L; Palermo A; Pichiecchio A; Paoletti M; Lucev F; Gerevini S; Rossi A; Vegezzi E; Diamanti L; Bini P; Gastaldi M; Delbue S; Perotti C; Seminari E; Faraci M; Luppi M; Baldanti F; Zecca M; Marchioni E; Comoli P
Ann Neurol; 2021 Apr; 89(4):769-779. PubMed ID: 33459417
[TBL] [Abstract][Full Text] [Related]
6. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
7. Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A
Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy after CAR T therapy.
Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
10. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
11. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
12. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration.
Dunham SR; Schmidt R; Clifford DB
Neurotherapeutics; 2020 Jul; 17(3):955-965. PubMed ID: 32166631
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
15. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
16. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy therapy.
Clifford DB
J Neurovirol; 2015 Dec; 21(6):632-6. PubMed ID: 25227934
[TBL] [Abstract][Full Text] [Related]
18. Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.
Nelson AS; Yalamarthi N; Yong MK; Blyth E
Curr Opin Infect Dis; 2021 Dec; 34(6):627-634. PubMed ID: 34751182
[TBL] [Abstract][Full Text] [Related]
19. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
20. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
